HomePHAT • NASDAQ
add
Phathom Pharmaceuticals Inc
Previous close
$12.06
Day range
$11.51 - $12.20
Year range
$2.21 - $19.71
Market cap
839.97M USD
Avg Volume
1.14M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 39.50M | 439.36% |
Operating expense | 94.39M | 13.38% |
Net income | -75.81M | 17.10% |
Net profit margin | -191.91 | 84.63% |
Earnings per share | -0.79 | 36.80% |
EBITDA | -59.75M | 22.50% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 149.57M | -45.85% |
Total assets | 250.22M | -21.65% |
Total liabilities | 656.05M | 18.59% |
Total equity | -405.83M | — |
Shares outstanding | 70.94M | — |
Price to book | -2.08 | — |
Return on assets | -55.03% | — |
Return on capital | -75.87% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -75.81M | 17.10% |
Cash from operations | -62.73M | 11.30% |
Cash from investing | -97.00K | -110.87% |
Cash from financing | 80.00K | -99.68% |
Net change in cash | -62.75M | -36.42% |
Free cash flow | -42.43M | 19.95% |
About
Founded
2018
Headquarters
Website
Employees
427
